Heartbeat Digital to Speak at FDA Hearing

NEW YORK--(Business Wire)--
Heartbeat Digital CEO Bill Drummy has been selected to speak at the upcoming
Public Hearing on Promotion of FDA-Regulated Medical Products Using the Internet
and Social Media Tools. The hearing will take place on November 12 and 13 in
Washington, D.C. and will focus on "the continually evolving nature of the
internet, including Web 2.0 and social-media tools, as well as their expansion
to applications such as mobile technology".

Mr. Drummy will be providing his point of view on such topics as what types of
online communications pharmaceutical companies should be held accountable for,
how those companies should be required to fulfill regulatory requirements with
the inherent space limitations of social media and how adverse event reporting
should be handled.

Heartbeat will be tweeting live from the hearing; follow the events at
@heartbeatny.

In anticipation of the hearing, Mr. Drummy said, "Up to this point there have
been no guidelines regarding digital pharmaceutical marketing, which has really
put pharma companies in a straitjacket when it comes to using social media. So
we applaud the effort and are hopeful the hearing will lead to clear guidance
and expanded use of social media which will greatly help patients in the
management of their health."

The hearing will feature a cross-section of speakers including consumers,
pharmaceutical companies, digital agencies, research firms, bloggers, social
networking experts, and non-profit groups.

Mr. Drummy has outlined his point of view regarding new social media
developments and the FDA hearing in the paper, "Thinking Deeper about Sidewiki
and the FDA: Why the obvious advice might just be wrong". Download the POV at
www.heartbeatdigital.com/pdf/Thinking_Deeper.pdf

------

Heartbeat is one of the country`s leading privately held, interactive marketing
and software companies. Founded in 1998, the company conceives and creates sales
and marketing solutions for the consumer products, healthcare and luxury
industries.

The agency`s healthcare clients include Amgen, Auxilium, Bayer, Becton
Dickinson, Cephalon, Endo Pharmaceuticals, Life Line Screening, Mayo Clinic,
Memorial Sloan-Kettering Cancer Center, Merck, Millennium, Otsuka,
sanofi-aventis, and UCB.

Heartbeat Digital publishes a daily blog and newsletter, The Pulse, a rich
repository of news about digital marketing trends at pulse.heartbeatdigital.com,
available for free for current and prospective Heartbeat clients.

Heartbeat Digital
Jared Watson, 212-284-9627
jaredw@heartbeatdigital.com

Copyright Business Wire 2009